Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Goldstein

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Journal of the American College of Cardiology|October 9, 2024
Bivalirudin vs Heparin Anticoagulation in STEMI: Confirmation of the BRIGHT-4 ResultsGregg W Stone, Marco Valgimigli, David Erlinge, et al.
Circulation|July 2, 2008
Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI)Nicolas Danchin, Pierre Coste, Jean Ferrières, et al.
The American Journal of Cardiology|September 10, 2013
A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial)Jean-Philippe Collet, Kurt Huber, Marc Cohen, et al.
Circulation|September 25, 2023
Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized TrialsBehnood Bikdeli, David Erlinge, Marco Valgimigli, et al.
The New England Journal of Medicine|September 3, 2013
Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromesGilles Montalescot, Leonardo Bolognese, Dariusz Dudek, et al.
Journal of the American College of Cardiology|April 23, 2016
Early Aldosterone Blockade in Acute Myocardial Infarction: The ALBATROSS Randomized Clinical TrialFarzin Beygui, Guillaume Cayla, Vincent Roule, et al.
Archives of Cardiovascular Diseases|June 26, 2017
French Registry on Acute ST-elevation and non-ST-elevation Myocardial Infarction 2015 (FAST-MI 2015). Design and baseline dataLoïc Belle, Guillaume Cayla, Yves Cottin, et al.
Lancet (London, England)|August 23, 2011
Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trialGilles Montalescot, Uwe Zeymer, Johanne Silvain, et al.
JAMA|May 8, 2019
Effect of Trans-Nasal Evaporative Intra-arrest Cooling on Functional Neurologic Outcome in Out-of-Hospital Cardiac Arrest: The PRINCESS Randomized Clinical TrialPer Nordberg, Fabio Silvio Taccone, Anatolij Truhlar, et al.
The New England Journal of Medicine|March 12, 2013
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarctionPaul W Armstrong, Anthony H Gershlick, Patrick Goldstein, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Journal of the American College of Cardiology|October 9, 2024
Bivalirudin vs Heparin Anticoagulation in STEMI: Confirmation of the BRIGHT-4 ResultsGregg W Stone, Marco Valgimigli, David Erlinge, et al.
Circulation|July 2, 2008
Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI)Nicolas Danchin, Pierre Coste, Jean Ferrières, et al.
The American Journal of Cardiology|September 10, 2013
A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial)Jean-Philippe Collet, Kurt Huber, Marc Cohen, et al.
Circulation|September 25, 2023
Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized TrialsBehnood Bikdeli, David Erlinge, Marco Valgimigli, et al.
The New England Journal of Medicine|September 3, 2013
Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromesGilles Montalescot, Leonardo Bolognese, Dariusz Dudek, et al.
Journal of the American College of Cardiology|April 23, 2016
Early Aldosterone Blockade in Acute Myocardial Infarction: The ALBATROSS Randomized Clinical TrialFarzin Beygui, Guillaume Cayla, Vincent Roule, et al.
Archives of Cardiovascular Diseases|June 26, 2017
French Registry on Acute ST-elevation and non-ST-elevation Myocardial Infarction 2015 (FAST-MI 2015). Design and baseline dataLoïc Belle, Guillaume Cayla, Yves Cottin, et al.
Lancet (London, England)|August 23, 2011
Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trialGilles Montalescot, Uwe Zeymer, Johanne Silvain, et al.
JAMA|May 8, 2019
Effect of Trans-Nasal Evaporative Intra-arrest Cooling on Functional Neurologic Outcome in Out-of-Hospital Cardiac Arrest: The PRINCESS Randomized Clinical TrialPer Nordberg, Fabio Silvio Taccone, Anatolij Truhlar, et al.
The New England Journal of Medicine|March 12, 2013
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarctionPaul W Armstrong, Anthony H Gershlick, Patrick Goldstein, et al.
Pageof 10